Intel has strengthened its position in the industrial edge computing market by unveiling a new edge processor that simultaneously supports real-time data processing and AI computation in industrial settings.

Intel unveiled the 'Intel Core processor Series 2' equipped with the industrial platform P-core at 'Embedded World 2026' held in Nuremberg, Germany on March 10, and also announced the 'Edge AI suite for Health & Life Sciences' for the healthcare and life sciences fields.

According to Intel, the Core Series 2 processors are designed with the real-time processing and reliability demands of industrial environments in mind. Industrial environments require the simultaneous execution of diverse workloads, such as safety control systems and real-time data processing, while maintaining precise timing and deterministic performance. Existing systems often require a trade-off between computational performance and real-time reliability, often requiring a multiprocessor architecture.

The new processor focuses on improving these structural limitations. Intel says the product offers up to 4.4x lower PCIe latency, up to 2.5x better deterministic response time, and up to 3.8x better deterministic performance compared to the AMD Ryzen 7 9700X. It also boasts up to 1.5x better multi-threaded performance.

Intel also unveiled a preview version of its Edge AI Suite, targeting healthcare and life sciences. This solution provides reference pipelines and benchmarking tools to support the development of AI-based patient monitoring systems. The company explained that with increasing patient volumes and increasing staffing shortages in healthcare settings, patient monitoring technology is rapidly expanding from a single-device environment to a data-driven, connected system.

The suite presents scenarios for running a variety of multimodal AI workloads locally on Intel processors, including electrocardiogram-based arrhythmia detection, remote photoplethysmography, and anonymized 3D visual tracking. This enables OEMs, ODMs, and independent software vendors (ISVs) to evaluate platform performance under conditions close to real-world use.

Dan Rodriguez, vice president and general manager of Intel's Edge Computing Group, said that edge computing is one of Intel's key growth areas, and that with the Core Series 2, Core Ultra Series 3, and the expansion of the Edge AI suite, Intel is providing an integrated platform that supports the edge AI needs of various industries.

Intel expects this product line to expand the use of edge computing environments that simultaneously perform real-time control and AI-based analysis across a wide range of industries, including manufacturing and healthcare.